Xpand Biotech, operating under the brand name Kuros Biosciences, is a pioneering company in the field of bone healing and spinal fusion technologies. The company focuses on developing advanced bone graft solutions that aim to improve patient outcomes by promoting targeted and controlled bone healing. Their flagship product, MagnetOs, is a unique bone graft with a specialized surface that encourages uniform and stable spinal fusions. This product leverages osteoimmunology, which is the study of the interaction between the immune system and bone, to enhance bone healing without the need for added cells or growth factors.

Kuros Biosciences serves a diverse range of clients, primarily targeting healthcare providers such as hospitals, orthopedic surgeons, and spine specialists. The company operates in the medical technology market, specifically within the niche of bone grafting and spinal fusion solutions. Their business model revolves around the research, development, and commercialization of innovative bone healing products. They generate revenue through the sale of these products to medical institutions and through partnerships with distributors.

The company has also made significant strides in drug development. Their Fibrin PTH KUR-113 product, a combination of a drug and a biologic, has received approval from the U.S. Food and Drug Administration (FDA) to enter Phase 2a clinical trials. This product is designed for spinal interbody fusion, a procedure that involves fusing two or more vertebrae to prevent movement and alleviate pain.

Kuros Biosciences engages with its clients and stakeholders through various channels, including personal consultations with scientific experts, training sessions for distributors, and virtual sessions with spine surgeons. These initiatives aim to educate and inspire their clients, ensuring they are well-informed about the latest advancements and applications of their products.

Keywords: bone healing, spinal fusion, MagnetOs, osteoimmunology, healthcare, orthopedic, FDA approval, clinical trials, medical technology, Kuros Biosciences.